HCP, Inc. (NYSE:HCP) Receives Consensus Recommendation of “Hold” from Analysts

HCP, Inc. (NYSE:HCP) has received a consensus rating of “Hold” from the twenty-one brokerages that are currently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, fifteen have assigned a hold recommendation and four have given a buy recommendation to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $32.75.

Several brokerages recently weighed in on HCP. UBS AG upgraded HCP from an “underperform” rating to an “outperform” rating in a research report on Wednesday, June 14th. BidaskClub upgraded HCP from a “hold” rating to a “buy” rating in a research report on Wednesday, June 21st. Stifel Nicolaus reiterated a “hold” rating and issued a $31.00 price objective on shares of HCP in a research report on Friday, July 14th. Mizuho reiterated a “neutral” rating on shares of HCP in a research report on Wednesday, June 28th. Finally, Bank of America Corporation upgraded HCP from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $33.25 to $35.00 in a research report on Monday, April 3rd.

TRADEMARK VIOLATION NOTICE: “HCP, Inc. (NYSE:HCP) Receives Consensus Recommendation of “Hold” from Analysts” was originally published by Transcript Daily and is owned by of Transcript Daily. If you are accessing this story on another website, it was illegally copied and republished in violation of United States and international copyright laws. The correct version of this story can be viewed at https://transcriptdaily.com/2017/07/23/hcp-inc-nysehcp-receives-consensus-recommendation-of-hold-from-analysts.html.

In other news, insider Thomas Klaritch sold 2,651 shares of the stock in a transaction on Tuesday, June 13th. The stock was sold at an average price of $31.53, for a total value of $83,586.03. Following the sale, the insider now directly owns 176,830 shares in the company, valued at $5,575,449.90. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.22% of the stock is currently owned by company insiders.

Several hedge funds have recently made changes to their positions in the stock. Cleararc Capital Inc. boosted its stake in shares of HCP by 0.7% in the first quarter. Cleararc Capital Inc. now owns 11,441 shares of the real estate investment trust’s stock valued at $358,000 after buying an additional 85 shares during the last quarter. Peoples Financial Services CORP. boosted its stake in shares of HCP by 4.0% in the second quarter. Peoples Financial Services CORP. now owns 3,250 shares of the real estate investment trust’s stock valued at $104,000 after buying an additional 125 shares during the last quarter. Transamerica Financial Advisors Inc. boosted its stake in shares of HCP by 0.9% in the first quarter. Transamerica Financial Advisors Inc. now owns 17,030 shares of the real estate investment trust’s stock valued at $533,000 after buying an additional 145 shares during the last quarter. Atria Investments LLC boosted its stake in shares of HCP by 1.2% in the second quarter. Atria Investments LLC now owns 12,447 shares of the real estate investment trust’s stock valued at $398,000 after buying an additional 147 shares during the last quarter. Finally, Curbstone Financial Management Corp boosted its stake in shares of HCP by 0.5% in the first quarter. Curbstone Financial Management Corp now owns 31,185 shares of the real estate investment trust’s stock valued at $975,000 after buying an additional 150 shares during the last quarter. Institutional investors and hedge funds own 88.27% of the company’s stock.

HCP (NYSE HCP) traded down 0.47% during mid-day trading on Tuesday, hitting $31.59. The company had a trading volume of 3,303,960 shares. The company has a 50-day moving average price of $32.00 and a 200 day moving average price of $31.25. HCP has a 12 month low of $27.61 and a 12 month high of $40.43. The firm has a market capitalization of $14.80 billion, a P/E ratio of 15.23 and a beta of 0.37.

HCP (NYSE:HCP) last issued its quarterly earnings data on Tuesday, May 2nd. The real estate investment trust reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.03. The company had revenue of $492.16 million during the quarter, compared to analyst estimates of $514.82 million. HCP had a return on equity of 12.39% and a net margin of 41.38%. The firm’s revenue for the quarter was down 5.4% compared to the same quarter last year. During the same period in the prior year, the business posted $0.69 earnings per share. Equities analysts forecast that HCP will post $1.35 EPS for the current fiscal year.

HCP Company Profile

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Analyst Recommendations for HCP (NYSE:HCP)

Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply